Literature DB >> 15549359

Improving MS patient care.

Peter Rieckmann1.   

Abstract

Multiple sclerosis (MS) is a multidimensional, chronic, neurological disease affecting young people that often interferes with their life and career plans. Patient care begins at the time of diagnosis, and particular emphasis should be placed on proper education about the variable disease course and treatment options. Clinical assessment at regular intervals using quantitative measures is recommended in order to obtain important information on the effects of disease-modifying and/or symptomatic treatment. In addition to optimising therapy, it is imperative to develop effective and properly resourced care services for MS patients that will address their complex and lifelong requirements.

Entities:  

Mesh:

Year:  2004        PMID: 15549359     DOI: 10.1007/s00415-004-1511-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  12 in total

1.  The cost of delaying treatment in multiple sclerosis: what is lost is not regained.

Authors:  S R Schwid; C T Bever
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

2.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Authors:  L D Jacobs; R W Beck; J H Simon; R P Kinkel; C M Brownscheidle; T J Murray; N A Simonian; P J Slasor; A W Sandrock
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

3.  Cost-utility analysis of interferon beta-1B in secondary progressive multiple sclerosis using natural history disease data.

Authors:  Gisela Kobelt; Linus Jönsson; Carolin Miltenburger; Bengt Jönsson
Journal:  Int J Technol Assess Health Care       Date:  2002       Impact factor: 2.188

4.  Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.

Authors:  G Comi; M Filippi; F Barkhof; L Durelli; G Edan; O Fernández; H Hartung; P Seeldrayers; P S Sørensen; M Rovaris; V Martinelli; O R Hommes
Journal:  Lancet       Date:  2001-05-19       Impact factor: 79.321

5.  PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

Authors: 
Journal:  Neurology       Date:  2001-06-26       Impact factor: 9.910

Review 6.  Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis.

Authors:  Oscar Fernández
Journal:  J Neurol       Date:  2002-01       Impact factor: 4.849

Review 7.  [Immunomodulatory staged therapy of multiple sclerosis. New aspects and practical applications, March 2002].

Authors:  P Rieckmann; K V Toyka
Journal:  Nervenarzt       Date:  2002-06       Impact factor: 1.214

Review 8.  From inflammation to degeneration: the lessons of clinical trials.

Authors:  G Comi
Journal:  Neurol Sci       Date:  2003-12       Impact factor: 3.307

9.  Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis.

Authors:  P M Rothwell; Z McDowell; C K Wong; P J Dorman
Journal:  BMJ       Date:  1997-05-31

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  3 in total

1.  Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.

Authors:  Roya Abolfazli; Azam Elyasi; Mohammad Reza Javadi; Kheirollah Gholami; Hassan Torkamandi; Mohammad Amir-Shahkarami; Masoud Etemadifar; Zahra Nasr
Journal:  Iran J Neurol       Date:  2014-07-04

Review 2.  Multiple Sclerosis: Immunopathology and Treatment Update.

Authors:  Narges Dargahi; Maria Katsara; Theodore Tselios; Maria-Eleni Androutsou; Maximilian de Courten; John Matsoukas; Vasso Apostolopoulos
Journal:  Brain Sci       Date:  2017-07-07

3.  The study circle as a tool in multiple sclerosis patient education in Sweden.

Authors:  Anne-Marie Landtblom; Cecilia Lang; Gullvi Flensner
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.